Quoin Pharmaceuticals

Quoin Pharmaceuticals develops QRX003 and QRX009 for rare and orphan diseases including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Pachyonychia Congenita, Gorlin Syndrome, Tuberous Sclerosis Complex, and lymphatic and venous malformations.